Eur Rev Med Pharmacol Sci 2019; 23 (19): 8303-8309

DOI: 10.26355/eurrev_201910_19141

LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p

C. Zhang, G.-X. Wang, B. Fu, X.-C. Zhou, Y. Li, Y.-Y. Li

Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China. easily008@163.com


OBJECTIVE: Prostate cancer (PC) is one of the most ordinary malignant cancers. Recent researches have proved that long noncoding RNAs (lncRNAs) act as an important role in cancers. Our study aims to explore the function of lncRNA CASC15 in the tumor metastasis of PC.

PATIENTS AND METHODS: Real Time-quantitative Polymerase Chain Reaction (RT-qPCR) was utilized to detect CASC15 expression in 50 PC patients. Besides, the wound healing assay and transwell assay were performed to identify the biological behavior changes of PC cells after CASC15 was silenced in PC cells. In addition, the potential mechanism was also explored using the luciferase assay.

RESULTS: CASC15 expression level was significantly higher in PC tissues and cell lines. Results of wound healing assay and transwell assay revealed that cell migrated ability and invaded ability were suppressed via silence of CASC15 in PC cells. Furthermore, the expression of miR-200a-3p was upregulated via silence of CASC15 in PC cells. Luciferase assay showed that miR-200a-3p was a direct target of CASC15 in PC. In addition, miR-200a-3p expression was negatively correlated with CASC15 expression in PC tissues. Rescue experiments also revealed that the inhibition of PC migration and invasion by silence of CASC15 could be reversed through knockdown of miR-200a-3p.

CONCLUSIONS: Our study uncovers that CASC15 could enhance cell migration and invasion of PC cells by sponging miR-200a-3p, which might be applied as a novel therapeutic target for PC patients.

Free PDF Download

To cite this article

C. Zhang, G.-X. Wang, B. Fu, X.-C. Zhou, Y. Li, Y.-Y. Li
LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 19
Pages: 8303-8309
DOI: 10.26355/eurrev_201910_19141